Company intelligence / Profile preview

Charles Stiefel

Research Triangle Park, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Stiefel Laboratories is a global leader in the field of dermatology, specializing in the development and commercialization of skin care products and therapeutic treatments. Founded in 1847, the company built a vast portfolio of prescription and over-the-counter products targeting conditions such as acne, psoriasis, and eczema. In 2009, the company was acquired by GSK for approximately $2.9 billion, becoming GSK's primary dermatology business unit. Today, it continues to operate as a subsidiary of GSK, leveraging its long history in dermatological science to provide specialized skin health solutions worldwide.

Therapeutic areas: Infectious DiseasesOncologyDermatology
Modalities: Small moleculeTopical formulation
Industry: Biotech

Drug pipeline

1 asset

ciclopirox olamine

Approved

Partnerships

GSK

Beyond the preview

Go deeper on Charles Stiefel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Charles Stiefel.

Explore the full profile